Suchbegriffe: REFRACTORY SOLID TUMORS, . Treffer: 2
Pansy, J; Fritsch, P; Sovinz, P; Lackner, H; Schwinger, W; Urban, C; Benesch, M
Add-on-therapy with bevacizumab in children and adolescents with poor prognosis non-CNS solid tumors.
Anticancer Drugs. 2013; 24(2):198-203
Doi: 10.1097/CAD.0b013e32835b9589
Web of Science
PubMed
FullText
FullText_MUG
Benesch, M; Windelberg, M; Sauseng, W; Witt, V; Fleischhack, G; Lackner, H; Gadner, H; Bode, U; Urban, C
Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors.
Ann Oncol. 2008; 19(4): 807-813.
Doi: 10.1093/annonc/mdm510
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG